This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
User:Alexander Lee Schmidt/Sandbox 1
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==NitroDur== | ==NitroDur== | ||
| - | <StructureSection load='4fr8' size='340' side='right' caption=' | + | <StructureSection load='4fr8' size='340' side='right' caption='4FR8 Crystal structure of human aldehyde dehydrogenase-2 in complex with nitroglycerin' scene=''> |
==Structure== | ==Structure== | ||
The main ingredient of NitroDura is 1,2,3-propanetriol trinitrate a/k/a <scene name='74/745476/Nitroglycerinmolecule/1'>Nitroglycerin</scene>, which is the main ingredient in NitroDur. Nitroglycerin is broken down into nitric oxide that is bound to protein domains in smooth muscle, as seen in <scene name='74/745476/2o0c_molecule/2'>Nitric Oxide bound to the domain of Nostoc cyanbacterial protein</scene>. | The main ingredient of NitroDura is 1,2,3-propanetriol trinitrate a/k/a <scene name='74/745476/Nitroglycerinmolecule/1'>Nitroglycerin</scene>, which is the main ingredient in NitroDur. Nitroglycerin is broken down into nitric oxide that is bound to protein domains in smooth muscle, as seen in <scene name='74/745476/2o0c_molecule/2'>Nitric Oxide bound to the domain of Nostoc cyanbacterial protein</scene>. | ||
Revision as of 22:44, 8 November 2016
NitroDur
| |||||||||||
References
- ↑ 1.0 1.1 ”>Tryzelaar, Dr. "Nitroglycerin (NTG)." Nitroglycerin (NTG). N.p., n.d. Web. 16 Oct. 2016”
- ↑ "NITRO-DUR® TRANSDERMAL DELIVERY SYSTEM." N.p., 3 Oct. 2014. Web. 16 Oct. 2016
- ↑ Heer T, Reiter S, Trissler M, Hofling B, von Knobelsdorff-Brenkenhoff F, Pilz G. Effect of Nitroglycerin on the Performance of MR Coronary Angiography. J Magn Reson Imaging. 2016 Oct 12. doi: 10.1002/jmri.25483. PMID:27731913 doi:http://dx.doi.org/10.1002/jmri.25483
- ↑ Chronic Achilles Tendon Injury: An Overview." Hospital for Special Surgery. N.p., 1 June 2011. Web. 30 Oct. 2016
- ↑ Hunte G, Lloyd-Smith R. Topical glyceryl trinitrate for chronic Achilles tendinopathy. Clin J Sport Med. 2005 Mar;15(2):116-7. PMID:15782065
- ↑ 6.0 6.1 <ref>PMCID: PMC2860448</li> <li id="cite_note-6">[[#cite_ref-6|↑]] Haythornthwaite, Jenifer, Dr., and Fredrick Wigley, Dr. "Raynaud's, Finger and Skin Care." Scleroderma Education Program Chapter 2 Raynaud’s, Finger and Skin Care (n.d.): n. pag. Web. 16 Oct. 2016 </li> <li id="cite_note-7">[[#cite_ref-7|↑]] Heer T, Reiter S, Trissler M, Hofling B, von Knobelsdorff-Brenkenhoff F, Pilz G. Effect of Nitroglycerin on the Performance of MR Coronary Angiography. J Magn Reson Imaging. 2016 Oct 12. doi: 10.1002/jmri.25483. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/27731913 27731913] doi:[http://dx.doi.org/10.1002/jmri.25483 http://dx.doi.org/10.1002/jmri.25483]</li></ol></ref>
